These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35671933)

  • 1. Atopic keratoconjunctivitis alleviated with dupilumab.
    Chen J; Bielory L
    Ann Allergy Asthma Immunol; 2022 Sep; 129(3):375-376. PubMed ID: 35671933
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of dupilumab on atopic manifestations in patients treated for atopic dermatitis in real-life practice.
    Tauber M; Apoil PA; Richet C; Laurent J; De Bonnecaze G; Mouchon E; Cassagne M; Marguery MC; Hegazy S; Konstantinou MP; Severino M; Uthurriague C; Giordano-Labadie F; Didier A; Paul C
    Br J Dermatol; 2019 Jun; 180(6):1551-1552. PubMed ID: 30633329
    [No Abstract]   [Full Text] [Related]  

  • 3. Limbic Keratoconjunctivitis Associated With Dupilumab Treatment in Atopic Dermatitis.
    Lin RY; Sun G
    J Allergy Clin Immunol Pract; 2022 Sep; 10(9):2450-2451. PubMed ID: 35931626
    [No Abstract]   [Full Text] [Related]  

  • 4. Omalizumab for severe atopic keratoconjunctivitis.
    Taillé C; Doan S; Neukirch C; Aubier M
    BMJ Case Rep; 2010 Oct; 2010():. PubMed ID: 22791726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition of atopic keratoconjunctivitis during treatment with dupilumab for atopic dermatitis.
    Cheng J; Jiang L; Morrow NC; Avdic A; Fairley JA; Ling JJ; Greiner MA
    J Am Acad Dermatol; 2021 Jul; 85(1):265-267. PubMed ID: 32956738
    [No Abstract]   [Full Text] [Related]  

  • 6. Conjunctivitis in Dupilumab Clinical Trials for Adolescents with Atopic Dermatitis or Asthma.
    Bansal A; Simpson EL; Paller AS; Siegfried EC; Blauvelt A; de Bruin-Weller M; Corren J; Sher L; Guttman-Yassky E; Chen Z; Daizadeh N; Kamal MA; Shumel B; Mina-Osorio P; Mannent L; Patel N; Graham NMH; Khokhar FA; Ardeleanu M
    Am J Clin Dermatol; 2021 Jan; 22(1):101-115. PubMed ID: 33481203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atopic keratoconjunctivitis: A review.
    Chen JJ; Applebaum DS; Sun GS; Pflugfelder SC
    J Am Acad Dermatol; 2014 Mar; 70(3):569-75. PubMed ID: 24342754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Keratoconjunctivitis associated with atopic dermatitis treated with tocilizumab].
    Raga Jiménez C; Álvarez Martín T; Ferrando Piqueres R; Pitarch Bort G
    Farm Hosp; 2018 Jan; 42(1):29-30. PubMed ID: 29306313
    [No Abstract]   [Full Text] [Related]  

  • 9. Dupilumab-Associated Conjunctivitis in Patients With Atopic Dermatitis.
    Liberman P; Shifera AS; Berkenstock M
    Cornea; 2020 Jun; 39(6):784-786. PubMed ID: 31985517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amelioration of conjunctival giant papillae by dupilumab in patients with atopic keratoconjunctivitis.
    Fukuda K; Ebihara N; Kishimoto T; Fukushima A
    J Allergy Clin Immunol Pract; 2020 Mar; 8(3):1152-1155. PubMed ID: 31678297
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of Bacterial and Nonbacterial Conjunctivitis in Patients With Atopic Dermatitis Treated With Dupilumab: A US Multidatabase Cohort Study.
    Schneeweiss MC; Wyss R; Chin K; Merola JF; Silverberg JI; Mostaghimi A; Schneeweiss S
    Dermatitis; 2022 Nov-Dec 01; 33(6S):S73-S82. PubMed ID: 35170520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare case of vernal keratoconjunctivitis in a patient with atopic dermatitis treated with tralokinumab.
    Lai B; Phan K; Lewis N; Shumack S
    J Eur Acad Dermatol Venereol; 2022 May; 36(5):e343-e345. PubMed ID: 34807480
    [No Abstract]   [Full Text] [Related]  

  • 13. Ocular surface disease associated with dupilumab treatment for atopic diseases.
    Utine CA; Li G; Asbell P; Pflugfelder S; Akpek E
    Ocul Surf; 2021 Jan; 19():151-156. PubMed ID: 32439390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment and prevention of the recurrence of refractory vernal keratoconjunctivitis with dupilumab.
    Tsui MC; Chiang BL; Wang IJ
    Clin Exp Ophthalmol; 2022 Dec; 50(9):1100-1103. PubMed ID: 35907140
    [No Abstract]   [Full Text] [Related]  

  • 15. A Clinician's Guide to the Recognition and Management of Dupilumab-Associated Conjunctivitis.
    Agnihotri G; Shi K; Lio PA
    Drugs R D; 2019 Dec; 19(4):311-318. PubMed ID: 31728936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment.
    Nahum Y; Mimouni M; Livny E; Bahar I; Hodak E; Leshem YA
    Br J Ophthalmol; 2020 Jun; 104(6):776-779. PubMed ID: 31554632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of conjunctivitis with a conjunctival proliferative lesion in a patient treated with dupilumab for atopic dermatitis.
    Fukuda K; Ishida W; Kishimoto T; Fukushima A
    Allergol Int; 2019 Jul; 68(3):383-384. PubMed ID: 30718036
    [No Abstract]   [Full Text] [Related]  

  • 18. Real-world experience of dupilumab treatment for atopic dermatitis in adults: a retrospective analysis of patients' records.
    Wang C; Kraus CN; Patel KG; Ganesan AK; Grando SA
    Int J Dermatol; 2020 Feb; 59(2):253-256. PubMed ID: 31286499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis.
    Gkalpakiotis S; Arenberger P; Skalicka P; Arenbergerova M
    J Eur Acad Dermatol Venereol; 2020 Jun; 34(6):e281-e283. PubMed ID: 32031716
    [No Abstract]   [Full Text] [Related]  

  • 20. Reported Pregnancy Outcomes in Women With Severe Atopic Dermatitis Treated With Dupilumab: A Systematic Review.
    Akuffo-Addo E; Nicholas MN; Lansang P
    J Cutan Med Surg; 2023; 27(2):177-178. PubMed ID: 36721993
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.